Lifeward Ltd(LFWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LFWD Lifeward Ltd

Closed 04-27 16:00:00 EDT

7.49

+0.11

+1.49%

盘后7.49

+0.000.00%

16:34 EDT

High7.49	Low6.70	Vol8.52K
Open7.24	D1 Closing7.38	Amplitude10.70%
Mkt Cap28.35M	Tradable Cap28.21M	Total Shares3.78M
T/O60.78K	T/O Rate0.23%	Tradable Shares3.77M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LFWD","market":"US","secType":"STK","nameCN":"Lifeward Ltd","latestPrice":7.49,"timestamp":1777320000000,"preClose":7.38,"halted":0,"volume":8519,"hourTrading":{"tag":"盘后","latestPrice":7.49,"preClose":7.49,"latestTime":"16:34 EDT","volume":4,"amount":29.94,"timestamp":1777322075094,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.014905149051490558,"floatShares":3766400,"shares":3784700,"eps":-17.16,"marketStatus":"Closed","change":0.11,"latestTime":"04-27 16:00:00 EDT","open":7.24,"high":7.49,"low":6.7001,"amount":60782.1322,"amplitude":0.107033,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-17.16,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1777363200000},"marketStatusCode":5,"adr":0,"listingDate":1410494400000,"exchange":"NASDAQ","adjPreClose":7.38,"postHourTrading":{"tag":"盘后","latestPrice":7.49,"preClose":7.49,"latestTime":"16:34 EDT","volume":4,"amount":29.94,"timestamp":1777322075094,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.610891,"impliedVol":1.4291,"impliedVolPercentile":0.8558},"requestUrl":"/m/hq/s/LFWD/tweets","defaultTab":"tweets","newsList":[{"id":"2630934387","title":"Lifeward files to sell 7.26M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2630934387","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630934387?lang=en_us&edition=fundamental","pubTime":"2026-04-28 05:05","pubTimestamp":1777323912,"startTime":"0","endTime":"0","summary":"17:02 EDT Lifeward (LFWD) files to sell 7.26M ordinary shares for holders Published first on TheFly – the ultimate source for real-time, market-mov...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifeward-files-to-sell-7-26m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifeward-files-to-sell-7-26m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4604","LFWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629865107","title":"Lifeward says VP Jeannine Lynch to depart May 3 without cause","url":"https://stock-news.laohu8.com/highlight/detail?id=2629865107","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629865107?lang=en_us&edition=fundamental","pubTime":"2026-04-24 04:49","pubTimestamp":1776977391,"startTime":"0","endTime":"0","summary":"Lifeward set termination of Jeannine Lynch as vice president of strategy and market access effective May 3, 2026.Notice of departure was provided April 20, 2026.Exit will be treated as a termination without cause under Lynch’s employment agreement dated July 9, 2021.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 23, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDL1dGMbP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LFWD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627246139","title":"Lifeward files initial beneficial ownership statement for director Moshe H. Rozenbaum","url":"https://stock-news.laohu8.com/highlight/detail?id=2627246139","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627246139?lang=en_us&edition=fundamental","pubTime":"2026-04-14 06:42","pubTimestamp":1776120179,"startTime":"0","endTime":"0","summary":"Lifeward director Moshe H. Rozenbaum filed an initial Form 3 beneficial ownership statement dated March 25, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 13, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL7b0MqC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4604","LFWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624559825","title":"Lifeward appoints Rozenbaum, Sigsbee, Reznick to audit committee, regains Nasdaq compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2624559825","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624559825?lang=en_us&edition=fundamental","pubTime":"2026-04-01 05:39","pubTimestamp":1774993182,"startTime":"0","endTime":"0","summary":"Lifeward appointed Moshe Rozenbaum, William Mark Sigsbee, Yehuda Reznick to Audit Committee.Move followed resignation of Hadar Levy from board and Audit Committee.Nasdaq staff acknowledged March 30, 2026 that Lifeward is back in compliance, closing matter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL3SFBHk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624530347","title":"Oramed completes Oratech sale to Lifeward for shares, warrants, revenue-sharing payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2624530347","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624530347?lang=en_us&edition=fundamental","pubTime":"2026-04-01 04:22","pubTimestamp":1774988568,"startTime":"0","endTime":"0","summary":"Oramed completed sale of wholly owned unit Oratech Pharma to Lifeward on March 25, 2026.Transaction includes ongoing revenue-sharing payments set at 4% of net revenue from Lifeward ReWalk Personal Exoskeleton products and related extended warranties.Revenue-sharing term runs up to 10 years, subject to earlier cutoff tied to a maximum payment amount or Lifeward reaching $200 million market capitalization.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oramed Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL7nmf26:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4604","BK4007","LFWD","ORMP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622808469","title":"Lifeward files initial beneficial ownership statement; director Miriam Kidron reports no securities beneficially owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2622808469","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622808469?lang=en_us&edition=fundamental","pubTime":"2026-03-28 04:33","pubTimestamp":1774643600,"startTime":"0","endTime":"0","summary":"Miriam Kidron, a director at Lifeward, filed an initial Form 3 statement of beneficial ownership.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL5fMzQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4604","LFWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622007539","title":"Lifeward closes strategic partnership agreement with Oramed","url":"https://stock-news.laohu8.com/highlight/detail?id=2622007539","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622007539?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:45","pubTimestamp":1774471517,"startTime":"0","endTime":"0","summary":"Lifeward (LFWD) announced that it has closed on the company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals (ORM...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifeward-closes-strategic-partnership-agreement-with-oramed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifeward-closes-strategic-partnership-agreement-with-oramed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BK4604","LFWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622002681","title":"Lifeward issues $10 million senior secured convertible notes; private placement includes 2,256,476 ordinary shares and pre-funded warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2622002681","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622002681?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:31","pubTimestamp":1774470689,"startTime":"0","endTime":"0","summary":"Lifeward issues $10 million senior secured convertible notes; private placement includes 2,256,476 ordinary shares and pre-funded warrants. It also issued accompanying warrants to purchase ordinary shares.The unregistered issuance relied on Securities Act Section 4 and/or Rule 506 of Regulation D.The investors represented they were accredited investors acquiring the securities for investment purposes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDLblktcB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622004431","title":"Lifeward closes strategic partnership with Oramed; access to capital grows to $47 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622004431","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622004431?lang=en_us&edition=fundamental","pubTime":"2026-03-26 04:12","pubTimestamp":1774469547,"startTime":"0","endTime":"0","summary":"Lifeward closed a strategic partnership agreement with Oramed.Under the arrangement, Lifeward acquired Oramed’s clinical-stage Protein Oral Delivery  technology.The partnership provides Lifeward access to up to USD 47 million of capital from Oramed and certain investors.Lifeward accessed USD 10 million of that capital at the closing.The company also made changes to its board of directors in connection with the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to generate this news brief on March 25, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL3znJfR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","ORMP","BK4007","LFWD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621512387","title":"Lifeward receives Nasdaq notice over audit committee non-compliance under Listing Rule 5605(c)(2)(A)","url":"https://stock-news.laohu8.com/highlight/detail?id=2621512387","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621512387?lang=en_us&edition=fundamental","pubTime":"2026-03-21 04:31","pubTimestamp":1774038712,"startTime":"0","endTime":"0","summary":"Nasdaq notified Lifeward on March 17, 2026 that it is not in compliance with Listing Rule 5605 after Hadar Levy’s resignation reduced the audit committee to two members.Nasdaq rules require an audit committee of at least three members, and Lifeward is evaluating options to regain compliance under the cure period in Listing Rule 5605.The cure period runs until the earlier of the next annual shareholder meeting or February 24, 2027, with an August 24, 2026 deadline if the annual meeting is held before August 24, 2026.The notice does not immediately affect trading, and the ordinary shares continue to trade on the Nasdaq Capital Market under the symbol LFWD.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the origina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260320:nNDL8pMbsp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFWD","BK4604","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620228618","title":"Lifeward Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2620228618","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620228618?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:33","pubTimestamp":1773923580,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LFWD/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 08:33 ET (12:33 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LFWD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620246720","title":"Lifeward Ltd : H.c. Wainwright Raises Target Price to $10 From $4.5","url":"https://stock-news.laohu8.com/highlight/detail?id=2620246720","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620246720?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:12","pubTimestamp":1773915129,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN4070MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","LFWD","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620249366","title":"Lifeward price target adjusted to $10 from $4.50 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2620249366","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620249366?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:12","pubTimestamp":1773915123,"startTime":"0","endTime":"0","summary":"H.C. Wainwright adjusted the firm’s price target on Lifeward (LFWD) to $10 from $4.50 and keeps a Buy rating on the shares. The firm cites the comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lifeward-price-target-adjusted-to-10-from-4-50-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lifeward-price-target-adjusted-to-10-from-4-50-at-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4604","LFWD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620725189","title":"Lifeward Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2620725189","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620725189?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:31","pubTimestamp":1773840700,"startTime":"0","endTime":"0","summary":"Lifeward Ltd reports results for the quarter ended December 31 - Earnings SummaryLifeward Ltd LFWD.OQ reported a quarterly adjusted loss of $3.60 per share for the quarter ended December 31, higher th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL8N4061HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFWD","BK4082","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620535702","title":"Lifeward Q4 revenue fell 33% to USD 5.08 million as net loss narrowed 65% to USD 5.35 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620535702","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620535702?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:06","pubTimestamp":1773835593,"startTime":"0","endTime":"0","summary":"Lifeward published a quarterly and annual earnings press release reporting Q4 revenue of USD 5.08 million, down 33%, and FY revenue of USD 22.03 million, down 14%. Q4 gross margin was 21.4%, down 3 percentage points, while FY gross margin was 38.2%, up 6.2 percentage points. Q4 net loss was USD 5.35 million, down 65%, and FY net loss was USD 19.91 million, down 31%. In Q4, ReWalk Personal exoskeleton revenue rose 20% to USD 1.8 million on higher reimbursed unit sales, while AlterG revenue fell 43% to USD 3.2 million due to timing of orders from one international distributor expected to resume in 2026. Lifeward said it expects to close its strategic transaction with Oramed shortly after additional customary closing conditions are satisfied, and had USD 2.17 million of cash and cash equivalents as of Dec. 31, 2025.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1n0shz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00BGHQF748.EUR","BK4112","LU2095319765.USD","SG9999014039.USD","BK4604","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","BK4588","SG9999014013.SGD","BK4082","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","LU0314104364.USD","LU2210149790.SGD","LFWD","LU2210150020.SGD","IE00BN0W2V16.EUR","BK4585","NDAQ","SG9999014021.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620725358","title":"Lifeward Q4 Adj. EPS $(2.85) Misses $(1.08) Estimate, Sales $5.081M Miss $7.861M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2620725358","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620725358?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:04","pubTimestamp":1773835492,"startTime":"0","endTime":"0","summary":"Lifeward (NASDAQ:LFWD) reported quarterly losses of $(2.85) per share which missed the analyst consensus estimate of $(1.08) by 163.89 percent. This is a 37.5 percent increase over losses of $(4.56) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51321145/lifeward-q4-adj-eps-2-85-misses-1-08-estimate-sales-5-081m-miss-7-861m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LFWD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620837253","title":"Press Release: Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2620837253","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620837253?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:01","pubTimestamp":1773835260,"startTime":"0","endTime":"0","summary":"Advancing transformation into a diversified biomedical innovation company with a clear path to cash flow positive. Oramed strategic transaction receives shareholder approval; Lifeward gains new oral protein delivery technology platform. Lifeward already executing new strategy through acquisition of powered upper-body exoskeleton technology. Lower operating expenses and cash usage reflect improved operational efficiency. \"We are entering 2026 with a pivotal transaction that establishes Lifeward as a diversified biomedical innovation company positioned for long-term growth and sustainability,\" said Mark Grant, CEO of Lifeward. \"The transformative strategic investment agreement with Oramed introduces an entirely new technology platform to Lifeward through Oramed's Protein Oral Delivery  technology, while Oramed continues to fund and manage development of the clinical pipeline, whose lead asset is oral insulin. This transaction significantly expands our innovation pipeline while allowing u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4555","BK4604","BK4588","BK4099","LFWD","R","BK4232","BK4082","BK4585","BK4022","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619468925","title":"Lifeward Ltd  expected to post a loss of $1.08 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2619468925","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619468925?lang=en_us&edition=fundamental","pubTime":"2026-03-16 20:32","pubTimestamp":1773664322,"startTime":"0","endTime":"0","summary":"Lifeward Ltd  expected to post a loss of $1.08 a share - Earnings Preview Lifeward Ltd LFWD.OQ, LFWD.O is expected to  show a rise in quarterly revenue when it reports  results on March 18 for the per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nL8N40413Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4604","LFWD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619192818","title":"Lifeward Ltd. Held Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2619192818","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619192818?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:17","pubTimestamp":1773404277,"startTime":"0","endTime":"0","summary":"Lifeward Ltd. held an Extraordinary General Meeting of Shareholders on March 12, 2026. Shareholders approved the issuance of ordinary shares in connection with the Oratech Pharma acquisition and related financings, approved the election of two directors effective at the closing of the acquisition, approved compensation for external directors, approved an increase in shares available under the 2025 Incentive Compensation Plan, approved an equity grant to Chief Executive Officer Mark Grant, and approved the reappointment of Kost Forer Gabbay & Kasierer  as independent registered public accounting firm for the year ending December 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifeward Ltd. published the original content used to","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDLbnK83w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","BK4604"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619919428","title":"Lifeward to partner with Oramed in deal providing access to up to USD 47 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2619919428","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619919428?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:05","pubTimestamp":1773403523,"startTime":"0","endTime":"0","summary":"Lifeward shareholders approved the issuance of ordinary shares tied to a strategic partnership with Oramed. Under the agreement, Lifeward will integrate Oramed’s POD oral delivery technology, and Oramed will obtain a significant equity interest through ordinary shares and prefunded warrants. The investment structure provides Lifeward potential access to up to 47 million of capital through equity, convertible notes, milestone-based funding, and warrant coverage. Oramed is expected to manage and fund the POD platform’s clinical development under a clinical trial management agreement to be entered into at closing. The transaction is expected to close after customary closing conditions are satisfied.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL8ynpzS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LFWD","ORMP","BK4007","BK4604"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.golifeward.com","stockEarnings":[{"period":"1week","weight":0.0869},{"period":"1month","weight":0.1302},{"period":"3month","weight":-0.0829},{"period":"6month","weight":-0.0509},{"period":"1year","weight":-0.5816},{"period":"ytd","weight":0.0666}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.087},{"period":"3month","weight":0.0359},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3059},{"period":"ytd","weight":0.047}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.091793},{"month":2,"riseRate":0.5,"avgChangeRate":-0.042859},{"month":3,"riseRate":0.083333,"avgChangeRate":-0.12159},{"month":4,"riseRate":0.166667,"avgChangeRate":0.019689},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.035343},{"month":6,"riseRate":0.272727,"avgChangeRate":0.002189},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.030658},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.075308},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.017608},{"month":10,"riseRate":0.25,"avgChangeRate":-0.11045},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.100673},{"month":12,"riseRate":0.25,"avgChangeRate":-0.017045}],"exchange":"NASDAQ","name":"Lifeward Ltd","nameEN":"Lifeward Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lifeward Ltd(LFWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Lifeward Ltd(LFWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Lifeward Ltd,LFWD,Lifeward Ltd股票,Lifeward Ltd股票老虎,Lifeward Ltd股票老虎国际,Lifeward Ltd行情,Lifeward Ltd股票行情,Lifeward Ltd股价,Lifeward Ltd股市,Lifeward Ltd股票价格,Lifeward Ltd股票交易,Lifeward Ltd股票购买,Lifeward Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lifeward Ltd(LFWD),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Lifeward Ltd(LFWD) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}